发明申请
US20080200456A1 Substituted 8-Heteroaryl Xanthines 有权
取代的8-杂芳基黄嘌呤

Substituted 8-Heteroaryl Xanthines
摘要:
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
公开/授权文献
信息查询
0/0